22.97
-0.69 (-2.92%)
| Penutupan Terdahulu | 23.66 |
| Buka | 23.55 |
| Jumlah Dagangan | 587,496 |
| Purata Dagangan (3B) | 721,455 |
| Modal Pasaran | 1,186,618,240 |
| Harga / Pendapatan (P/E Ke hadapan) | 94.34 |
| Harga / Jualan (P/S) | 3.33 |
| Harga / Buku (P/B) | 4.30 |
| Julat 52 Minggu |
| Margin Keuntungan | 17.92% |
| Margin Operasi (TTM) | -9.46% |
| EPS Cair (TTM) | 1.12 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 17.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 7.98% |
| Nisbah Semasa (MRQ) | 4.11 |
| Aliran Tunai Operasi (OCF TTM) | 26.78 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 29.89 M |
| Pulangan Atas Aset (ROA TTM) | -5.20% |
| Pulangan Atas Ekuiti (ROE TTM) | 19.54% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Bercampur | Menaik |
| Diagnostics & Research (Global) | Bercampur | Menaik | |
| Stok | CareDx, Inc. | Menaik | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | 1.5 |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 4.0 |
| Purata | 1.10 |
|
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 3.22% |
| % Dimiliki oleh Institusi | 99.39% |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| BICKERSTAFF GEORGE | 22.97 | - | 9,795 | 224,991 |
| COHEN FRED E | 22.97 | - | 9,795 | 224,991 |
| COURNOYER CHRISTINE | 22.97 | - | 9,795 | 224,991 |
| GOLDBERG MICHAEL | 22.97 | - | 9,795 | 224,991 |
| GUNASEKARAN SURESH | 22.97 | - | 9,795 | 224,991 |
| HANNA JOHN WALTER JR | - | 23.87 | -39,681 | -946,279 |
| RIGGSBEE RICHARD BRYAN | 22.97 | - | 9,795 | 224,991 |
| VALANTINE HANNAH | 22.97 | 24.08 | -2,308 | -66,449 |
| Jumlah Keseluruhan Kuantiti Bersih | 16,781 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 337,218 | |||
| Purata Pembelian Keseluruhan ($) | 22.97 | |||
| Purata Jualan Keseluruhan ($) | 23.94 | |||
| Julat Insider ($) | ||||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| VALANTINE HANNAH | Pengarah | 15 Jun 2026 | Jual automatik (-) | 12,103 | 24.08 | 291,440 |
| HANNA JOHN WALTER JR | Pegawai | 15 Jun 2026 | Jual automatik (-) | 17,683 | 24.08 | 425,807 |
| GOLDBERG MICHAEL | Pengarah | 12 Jun 2026 | Diperolehi (+) | 9,795 | 22.97 | 224,991 |
| BICKERSTAFF GEORGE | Pengarah | 12 Jun 2026 | Diperolehi (+) | 9,795 | 22.97 | 224,991 |
| GUNASEKARAN SURESH | Pengarah | 12 Jun 2026 | Diperolehi (+) | 9,795 | 22.97 | 224,991 |
| COHEN FRED E | Pengarah | 12 Jun 2026 | Diperolehi (+) | 9,795 | 22.97 | 224,991 |
| RIGGSBEE RICHARD BRYAN | Pengarah | 12 Jun 2026 | Diperolehi (+) | 9,795 | 22.97 | 224,991 |
| COURNOYER CHRISTINE | Pengarah | 12 Jun 2026 | Diperolehi (+) | 9,795 | 22.97 | 224,991 |
| VALANTINE HANNAH | Pengarah | 12 Jun 2026 | Diperolehi (+) | 9,795 | 22.97 | 224,991 |
| HANNA JOHN WALTER JR | Pegawai | 11 Jun 2026 | Jual automatik (-) | 21,998 | 23.66 | 520,473 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |